Filing Flows › Cronos Group (CRON) › Cannabis extracts revenue
Cronos Group (CRON) Cannabis extracts revenue by quarter
Cronos Group's Cannabis extracts revenue was $15.5M in Q3 2026 (third quarter 2026), +12% from Q2 2026. Over the last 7 quarters it ranged from $8.4M (Q2 2025) to $15.5M (Q3 2026).
| Quarter | Cannabis extracts revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $15.5M | +12% | +55% |
| Q2 2026 | $13.8M | +20% | +65% |
| Q1 2026 | $11.5M | +6% | +33% |
| Q4 2025 | $10.8M | +8% | — |
| Q3 2025 | $10.0M | +19% | — |
| Q2 2025 | $8.4M | -3% | — |
| Q1 2025 | $8.6M | — | — |
Q3 2026 at a glance
Cronos Group, Q3 2026: revenue $83.9M (+72% year over year), operating margin 10.8%, net earnings $13.8M, operating cash flow $34.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Cronos Group's Cannabis extracts revenue?
Cronos Group's Cannabis extracts revenue was $15.5M in Q3 2026 (third quarter 2026), +12% from Q2 2026.
How has Cronos Group's Cannabis extracts revenue changed?
Over the last 7 quarters it ranged from $8.4M (Q2 2025) to $15.5M (Q3 2026).